Fig. 1From: High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCAHNRNPR overexpression in ESCA and pan-cancer. A HNRNPR mRNA was expressed in various pan-cancers. B The expression level of HNRNPR mRNA was evaluated by analyzing TCGA data in various pan-cancers. C, D The difference in HNRNPR expression between ESCA cancer tissue and normal tissue in the TCGA and GSE45670 datasets. E The difference in HNRNPR expression between ESCA cancer and para-cancerous tissues in the GSE20347 dataset. G, F The HNRNPR expression and score in cancer and para-cancerous tissues of patients with ESCA were detected by IHC. H The difference in HNRNPR mRNA expression between cancer and para-cancerous tissues of ESCA patients based on qPCR test. *PÂ <Â 0.05, **PÂ <Â 0.01, ***PÂ <Â 0.001Back to article page